February 4, 2010 (FinancialWire) — Misonix, Inc. (NASDAQ: MSON), a developer of ultrasonic medical device technology, said it has entered into a new, three-year distribution agreement with Brazil-based Neuro Orthopaedics Surgeries for the distribution of the company’s SonaStar ultrasonic surgical aspirator and the BoneScalpel ultrasonic bone cutter.

According to Misonix, the agreement provides Neuro Orthopaedics Surgeries with the right to sell exclusively in Brazil and includes minimum purchase requirements.

Neuro Orthopaedics Surgeries will be Misonix’s eighth distributor in Latin America, and one of over 30 export distributors worldwide.

Neuro Orthopaedics Surgeries’ special expertise is in neuro and spine surgery.

New York-based Misonix designs, develops, manufactures and markets therapeutic ultrasonic medical devices and laboratory equipment.

The firm’s medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications

FinancialWire(tm) is committed to serving the financial community through true journalism and providing relevant resources to investors. Standards-based, independent equity research on numerous public companies is available through the Investrend Research Syndicate (http://www.investrend.com/reports) written by FIRST Research Consortium (http://www.investrend.com/FIRST) member-providers. Free annual reports and company filings for companies mentioned in the news are available through the Investrend Information Syndicate (at http://investrend.ar.wilink.com/?level=279). FinancialWire(tm), in cooperation with the Investrend Broadcast Syndicate, also provides complete, daily conference call and webcast schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “FirstAlert(tm) Daily” (http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) website (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.